-
Post date
June 29, 2021
-
Posted by
Piers Eaton
-
Posted in
Cannabis, Cannabis Compound Database, cbdv, Complex Biotech Discovery Ventures, DELC., DELC.C, Delic, Delic Holdings, Eaton, Mushrooms, psilocybin, Psychedelics, research, Science, Scribes, Section 56, Section 56 exemption
-
Post date
June 28, 2021
-
Posted by
Piers Eaton
-
Posted in
Adelia Therapeutics, Biotech, Cash on had, Cash on hand, cybin, CYBN.NE, Eaton, financial results, Health Science, Milestones, mushroom, Mushrooms, psilocybin, Psychedelics, research, Science, Scribes, shrooms
-
Post date
June 17, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Dr. Bergethon, Eaton, Health Science, LSD, LSD research, Mind Medicine, MindMEd, mmed.ne, MNMD.Q, Psychedelics, research, SAB, Science, scientific advisory board, Scribes
-
Post date
June 17, 2021
-
Posted by
Piers Eaton
-
Posted in
Antigua and Barbuda, Eaton, Health Science, Mushrooms, Oral thin fim, OTF, psilocybin, Psychedelics, research, revive, Revive Therapeutics, RVV, RVV.C, Scribes, UHSA
-
Post date
April 27, 2021
-
Posted by
Lukas Kane
-
Posted in
5 best Canadian Biotechs, Biotech, Biotech collaborations, Bucillamine, Canadian Biotech, cancer treatment, Cannabis, clinical sites, Covid-19 treatment, CRO, CymaBay Therapeutics (CBAY.NASDAQ), Fabio Chianelli, Featured Content, Health Science, Institutional Review Board, Investigational new drug, IRB, Kane, liver disease, massive buying, mushroom, mushroom research, Mushrooms, Novotech, Pharm-Olam LLC, PharmaTher, PharmaTher (PHRM.C), Phase 3 FDA trial, Phase 3 trial, Psychedelics, research, resperitory viral infections, Revive Therapeutics, RVV.C, Scribes, Series, shrooms, stock price surge, undervalued bio tech companies, wealth creation